Jeffrey G.  Black net worth and biography

Jeffrey Black Biography and Net Worth

Jeffrey G. Black was named Chief Financial Officer in August 2021. Mr. Black has served in senior finance leadership roles for seven publicly-traded companies, most recently as Executive Vice President and Chief Financial Officer of Alphatec Holdings, Inc. (ticker: ATEC), a medical technology company. Previously, Mr. Black was Chief Financial Officer of Applied Proteomics, Inc., a non-invasive, proteomics-based diagnostics company, and as Chief Financial Officer of AltheaDx, Inc., a pharmacogenetics diagnostics company. Mr. Black is a Certified Public Accountant (inactive) and is a member of the Board of Directors of Cellana, Inc., an algae bioproducts company. Mr. Black received his B.S. in Business from the University of Arizona.

What is Jeffrey G. Black's net worth?

The estimated net worth of Jeffrey G. Black is at least $0.00 as of May 18th, 2023. Mr. Black owns 43,492 shares of Apollo Endosurgery stock worth more than $0 as of March 28th. This net worth approximation does not reflect any other investments that Mr. Black may own. Learn More about Jeffrey G. Black's net worth.

How do I contact Jeffrey G. Black?

The corporate mailing address for Mr. Black and other Apollo Endosurgery executives is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. Apollo Endosurgery can also be reached via phone at (512) 279-5100 and via email at [email protected]. Learn More on Jeffrey G. Black's contact information.

Has Jeffrey G. Black been buying or selling shares of Apollo Endosurgery?

Jeffrey G. Black has not been actively trading shares of Apollo Endosurgery during the past quarter. Most recently, on Monday, February 28th, Jeffrey G. Black bought 15,000 shares of Apollo Endosurgery stock. The stock was acquired at an average cost of $5.66 per share, with a total value of $84,900.00. Learn More on Jeffrey G. Black's trading history.

Who are Apollo Endosurgery's active insiders?

Apollo Endosurgery's insider roster includes John Barr (Director), Jeffrey Black (CFO), Neil Gagnon (Major Shareholder), Chas Mckhann (CEO), and David Pacitti (Director). Learn More on Apollo Endosurgery's active insiders.

Jeffrey G. Black Insider Trading History at Apollo Endosurgery

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/28/2022Buy15,000$5.66$84,900.00View SEC Filing Icon  
2/25/2022Buy15,000$5.48$82,200.00View SEC Filing Icon  
8/11/2021Buy25,000$8.75$218,750.0025,000View SEC Filing Icon  
See Full Table

Jeffrey G. Black Buying and Selling Activity at Apollo Endosurgery

This chart shows Jeffrey G Black's buying and selling at Apollo Endosurgery by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Apollo Endosurgery Company Overview

Apollo Endosurgery logo
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $9.94
Low: $9.87
High: $10.00

2 Week Range

Now: N/A

Volume

1,658,800 shs

Average Volume

1,432,125 shs

Market Capitalization

$579.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.31